GLP-1 drugs, such as Novo Nordisk’s Wegovy, have become popular for weight loss among US patients struggling with obesity. Despite significant weight-loss benefits, an analysis of US health insurance claims reveals that these medications may drive healthcare costs higher rather than reducing obesity-related expenses. According to data from Prime Therapeutics, a pharmacy benefits manager, US patients’ average annual medical expenses…
Category: October 2024
-
As competition heats up, Novo Nordisk’s share price declines
Danish pharmaceutical giant Novo Nordisk, renowned for its diabetes and weight loss drugs Ozempic and Wegovy, has experienced a significant share price drop of around 19% this month. This decline follows its market peak in June, driven by increasing competition from Eli Lilly, a key player in the same space. Eli Lilly has gained substantial momentum with its rival drugs,…
-
RHAP advocates for higher ‘sin’ taxes
The Rural Health Advocacy Project (RHAP) has launched a powerful campaign calling for increased taxes on sugary drinks, alcohol, and tobacco products. This movement, backed by a coalition of health tax advocates, seeks to reduce the consumption of harmful products and alleviate the financial pressure on South Africa’s public health system. Last week, RHAP brought together an alliance of health…
-
Government pushes for more family physicians in key roles
The Department of Health has announced plans to increase the number of family physicians serving as clinical managers in district hospitals. This move follows years of lobbying by the South African Academy of Family Physicians (SAAFP) for greater recognition of the role of family physicians in the country’s public health system. The push to appoint family physicians, described as “super…
-
Governance at Bonitas raises serious concerns
The growing unease surrounding the governance of Bonitas, South Africa’s second-largest medical scheme, continues to deepen. Recent responses from Bonitas and the Council for Medical Schemes (CMS) have done little to quell concerns about questionable practices. Instead of offering transparency, they appear to be dodging key allegations, leaving stakeholders with more questions than answers. Bonitas’s recent decisions, particularly regarding its…
-
GNU faces major showdown over National Health Insurance
The GNU (Government of National Unity) has been hit by its first significant cabinet clash, with ANC and DA ministers at odds over proposed spending plans. The most contentious issue at the centre of the debate is the National Health Insurance (NHI), a plan to reshape South Africa’s healthcare system. Insiders reported that tempers flared during an extended cabinet meeting…
-
Budget cuts leave critical health posts unfilled
The Health Department has faced significant challenges in 2023/24 due to severe budget cuts imposed by the Treasury, leaving nearly a quarter of its posts unfilled. Health Director-General Sandile Buthelezi presented these findings to Parliament last week during the department’s 2023/24 annual report review, citing the inability to fill 24.1% of the 1,122 national department posts as a critical issue.…
-
Trust in doctors fades in the digital age
Once revered as trusted authorities, medical doctors face a new challenge in the form of health influencers. With the rise of digital platforms like Facebook, TikTok, Instagram, and YouTube, these influencers are reshaping how people seek medical advice and health information. As more influencers leverage their expertise for financial gain, traditional trust in doctors is fading. Health influencers, such as…
-
SAPPF takes legal action against controversial NHI Act
The South African Private Practitioners Forum (SAPPF), the largest association of medical specialists, has taken legal action against the controversial National Health Insurance (NHI) Act. This move adds to the growing pressure on President Cyril Ramaphosa to reconsider the legislation, which has faced increasing opposition. The SAPPF filed an application with the High Court in Pretoria on October 1, asking…
-
CMS responds to Bonitas corruption allegations
The Council for Medical Schemes (CMS) has responded to Michael Avery’s recent column titled “Anatomy of a scandal: Bonitas said to have lost Sanlam’s trust” (October 14), which questioned the regulatory body’s oversight and raised concerns about long-standing contracts in the medical scheme industry. Avery’s article insinuated that the CMS has been passive as a regulator. However, the CMS pointed…
-
NHI poses a significant risk to SA’s economic reform
Francois Gouws, CEO of PSG Financial Services, has expressed concerns about the National Health Insurance (NHI) and its potential impact on South Africa’s economic reform efforts. After the company released its latest financial results, Gouws highlighted the uncertainty surrounding the NHI, which he called “the elephant in the room” for economic reform. Gouws emphasised that the lack of clarity around…
-
SAHPRA calls for Increased National Treasury funding
The SA Health Products Regulatory Authority (SAHPRA) is again seeking additional financial support from the National Treasury. Over-reliance on fee income has placed the authority in a precarious position, with CEO Boitumelo Semete stressing the risks involved during a recent presentation to parliament. The authority’s diminishing government grant and industry consolidation threaten its ability to function effectively. SAHPRA, established in…